CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma
1 clinical trials · Condition
◉ Watch CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma
| Record | Firm | Date |
|---|---|---|
| PA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma (NCT07188610) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2025-09-25 |
Track CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.